
  
    
      
        Background_NNP
        Substance_NNP P_NN (_( SP_NNP )_) is_VBZ a_DT peptide_NN neurotransmitter_NN that_WDT has_VBZ
        been_VBN shown_VBN to_TO play_VB a_DT role_NN in_IN nociception_NN ,_, smooth_JJ muscle_NN
        control_NN ,_, allergic_JJ responses_NNS ,_, inflammation_NN and_CC glandular_NN
        secretion_NN [_NN 1_CD ]_NN ._. The_DT amino_JJ acid_NN sequence_NN of_IN SP_NNP was_VBD
        determined_VBN in_IN 1970_CD [_NN 2_CD ]_NN after_IN being_VBG isolated_VBN from_IN mammalian_JJ
        gastrointestinal_NN tract_NN in_IN 1931_CD [_NN 3_CD ]_NN ._. SP_NNP acts_NNS as_IN an_DT agonist_NN
        at_IN the_DT SP_NNP receptor_NN (_( SPR_NNP )_) ,_, known_VBN as_IN the_DT neurokinin-_NN 1_CD
        receptor_NN (_( NK_NNP 1_LS )_) in_IN mammalian_JJ systems_NNS ._. SP_NNP activation_NN of_IN the_DT
        SPR_NNP ,_, a_DT G-_NNP protein-coupled_JJ receptor_NN ,_, has_VBZ a_DT variety_NN of_IN effects_NNS
        in_IN the_DT nervous_JJ system_NN including_VBG inhibition_NN of_IN the_DT M-_NNP type_NN K_NNP
        +_NN current_JJ (_( I_NN 
        M_NNP )_) [_NN 4_CD ]_NN ._. The_DT mechanistic_JJ properties_NNS of_IN
        the_DT SPR_NNP have_VBP been_VBN extensively_RB studied_VBN in_IN
        receptor-expression_JJ systems_NNS ._. When_WRB transfected_JJ into_IN Chinese_JJ
        hamster_NN ovary_JJ (_( CHO_NNP )_) cells_NNS ,_, activation_NN of_IN the_DT SPR_NNP results_NNS in_IN
        an_DT increase_NN in_IN intracellular_NN Ca_MD +_NN +_NN [_NN 5_CD ]_NN ,_, accumulation_NN of_IN
        inositol_NN phosphates_NNS and_CC cAMP_NN formation_NN [_NN 6_CD ]_NN ._.
        The_DT recent_JJ development_NN of_IN intense_JJ ,_, photostable_JJ and_CC
        pH-insensitive_JJ fluorophores_NNS ,_, along_IN with_IN improvements_NNS in_IN
        optical_JJ detection_NN systems_NNS ,_, has_VBZ led_VBN to_TO fluorophore_NN labeling_VBG
        of_IN many_JJ pharmacological_JJ agents_NNS ._. Fluorescent_NNP probes_NNS can_MD be_VB
        used_VBN to_TO directly_RB label_VB ligand-binding_JJ sites_NNS without_IN the_DT use_NN
        of_IN radioactivity_NN or_CC antibodies_NNS ._. Receptor-labeling_NNP with_IN a_DT
        fluorophore-conjugated_JJ agonist_NN provides_VBZ advantages_NNS over_IN
        these_DT conventional_JJ methods_NNS ._. The_DT production_NN of_IN antibodies_NNS to_TO
        the_DT receptor_NN protein_NN is_VBZ not_RB required_VBN ,_, as_IN the_DT labeled_VBN
        agonist_NN will_MD bind_NN directly_RB to_TO the_DT receptor_NN ._. Fluorescence_NNP
        rather_RB than_IN radioactivity_NN can_MD detect_VB the_DT labeled_VBN ligand_NN ,_,
        which_WDT provides_VBZ more_JJR information_NN on_IN the_DT localization_NN of_IN the_DT
        receptor_NN upon_IN SP_NNP activation_NN ._. In_IN addition_NN ,_, labeled_VBN agonists_NNS
        can_MD be_VB used_VBN in_IN live_VB cells_NNS ._. Therefore_RB ,_, the_DT use_NN of_IN
        fluorescently_RB labeled_VBN agents_NNS may_MD allow_VB a_DT more_RBR extensive_JJ
        investigation_NN into_IN various_JJ receptor_NN functions_NNS ._.
        Molecular_NNP Probes_NNP ,_, Inc_NNP ._. (_( Eugene_NNP ,_, OR_NNP )_) has_VBZ recently_RB
        synthesized_JJ five_CD fluorophore-conjugated_JJ analogs_NNS of_IN SP_NNP as_IN
        potential_JJ tools_NNS for_IN direct_JJ labeling_VBG of_IN the_DT SPR_NNP ._. Alexa_NNP 488_CD ,_,
        BODIPY_NNP Fl_NNP ,_, fluorescein_NN ,_, Oregon_NNP Green_NNP 488_CD and_CC
        tetramethylrhodamine_NN have_VBP been_VBN conjugated_JJ to_TO the_DT third_JJ
        amino_JJ acid_NN of_IN SP_NNP ,_, Lys_NNP 3_CD ._. The_DT amine_NN group_NN of_IN Lys_NNP provides_VBZ a_DT
        convenient_JJ reactive_JJ group_NN for_IN labeling_VBG SP_NNP without_IN altering_VBG
        its_PRP$ original_JJ amino_JJ acid_NN sequence_NN ._. Alexa_NNP 488_CD ,_, BODIPY_NNP Fl_NNP ,_,
        fluorescein_NN and_CC Oregon_NNP Green_NNP 488_CD are_VBP green_JJ fluorophores_NNS ,_,
        while_IN tetramethylrhodamine_NN is_VBZ a_DT red_JJ fluorophore_NN ._.
        We_PRP have_VBP compared_VBN the_DT receptor_NN activation_NN and_CC labeling_VBG of_IN
        five_CD newly_RB synthesized_JJ fluorescent_NN analogs_NNS of_IN SP_NNP ._. Each_DT of_IN
        the_DT probes_NNS has_VBZ been_VBN tested_VBN for_IN :_: 1_LS )_) ability_NN to_TO bind_NN to_TO the_DT
        receptor_NN ,_, 2_LS )_) receptor_NN activation_NN in_IN both_DT a_DT heterologous_JJ
        expression_NN system_NN and_CC in_IN native_JJ neurons_NNS and_CC 3_LS )_) fluorescence_NN
        labeling_VBG of_IN the_DT receptor_NN ._. This_DT study_NN provides_VBZ an_DT extensive_JJ
        characterization_NN of_IN the_DT new_JJ SP_NNP derivatives_NNS that_WDT will_MD
        provide_VB a_DT basis_NN for_IN future_JJ studies_NNS involving_VBG the_DT
        fluorescent_NN conjugates_NNS ._. Oregon_NNP Green_NNP 488_CD was_VBD found_VBN to_TO be_VB
        the_DT most_RBS useful_JJ fluorophore_NN for_IN labeling_VBG SP_NNP without_IN
        altering_VBG its_PRP$ biological_JJ activity_NN ,_, whereas_IN Alexa_NNP 488_CD
        drastically_RB altered_VBD the_DT binding_JJ and_CC activation_NN of_IN SP_NNP ._.
      
      
        Results_NNS
        
          Spectra_NNP properties_NNS of_IN fluorescent_NN analogs_NNS
          The_DT fluorescent_NN properties_NNS of_IN a_DT fluorophore_NN can_MD change_VB
          when_WRB the_DT fluorophore_NN is_VBZ attached_VBN to_TO another_DT molecule_NN ,_, in_IN
          this_DT case_NN a_DT peptide_NN ._. Furthermore_RB ,_, the_DT conditions_NNS under_IN
          which_WDT fluorescence_NN is_VBZ measured_VBN ,_, such_JJ as_IN pH_NN ,_, ionic_JJ
          strength_NN and_CC buffer_NN composition_NN ,_, can_MD affect_VB fluorescence_NN ._.
          The_DT absorption_NN and_CC emission_NN spectra_NN of_IN the_DT fluorescent_NN SP_NNP
          analogs_NNS were_VBD assessed_VBN to_TO determine_VB their_PRP$ fluorescence_NN
          under_IN experimental_JJ conditions_NNS used_VBN here_RB ._. As_IN shown_VBN in_IN Fig_NNP ._.
          2_LS ,_, the_DT peak_NN excitations_NNS of_IN Alexa_NNP 488_CD -_: SP_NNP ,_, BODIPY_NNP Fl-_NNP SP_NNP ,_,
          fluorescein-_NN SP_NNP ,_, Oregon_NNP Green_NNP 488_CD -_: SP_NNP and_CC
          tetramethylrhodamine-_NN SP_NNP were_VBD 490_CD nm_NN ,_, 505_CD nm_NN ,_, 495_CD nm_NN ,_, 495_CD
          nm_NN and_CC 560_CD nm_NN ,_, respectively_RB ._. The_DT peaks_NNS of_IN the_DT emission_NN
          curves_NNS were_VBD 515_CD nm_NN ,_, 510_CD nm_NN ,_, 520_CD nm_NN ,_, 520_CD nm_NN and_CC 575_CD nm_NN ,_,
          respectively_RB ._.
        
        
          Epifluorescence_NNP microscopy_NN
          Direct-labeling_NNP of_IN the_DT SPR_NNP with_IN fluorescent_NN ligands_NNS
          like_IN those_DT analyzed_VBN in_IN this_DT study_NN would_MD offer_VB advantages_NNS
          over_IN current_JJ methods_NNS of_IN receptor_NN labeling_VBG ._. Some_DT of_IN these_DT
          advantages_NNS include_VBP the_DT ability_NN to_TO label_VB live_VB cells_NNS and_CC
          the_DT ability_NN to_TO conduct_VB receptor_NN labeling_VBG without_IN
          antibodies_NNS or_CC radioactive_JJ ligands_NNS ._. Therefore_RB ,_, an_DT
          important_JJ characteristic_NN of_IN the_DT fluorescent_NN SP_NNP analogs_NNS is_VBZ
          their_PRP$ ability_NN to_TO bind_NN to_TO the_DT SPR_NNP and_CC to_TO fluoresce_NN under_IN
          physiological_JJ conditions_NNS ._. In_IN order_NN to_TO observe_VB the_DT
          direct-labeling_JJ of_IN the_DT SP_NNP conjugates_NNS to_TO the_DT SPR_NNP ,_, CHO_NNP
          cells_NNS expressing_VBG the_DT rat_NN SPR_NNP (_( rSPR_NN )_) ,_, were_VBD incubated_JJ with_IN
          the_DT SP_NNP analogs_NNS (_( 100_CD nM_NN )_) for_IN 2_CD hrs_NNS at_IN 4_CD °_NN C_NNP ,_, to_TO prevent_VB
          internalization_NN of_IN the_DT receptor_NN ,_, rinsed_JJ and_CC fixed_VBN ._. Under_IN
          these_DT conditions_NNS ,_, all_DT of_IN the_DT labeled_VBN forms_NNS of_IN SP_NNP ,_, except_IN
          for_IN Alexa_NNP 488_CD -_: SP_NNP ,_, produced_VBD bright_JJ membrane_NN staining_VBG (_( Fig_NNP ._.
          3_LS )_) ._. Observation_NNP of_IN transfected_JJ cells_NNS incubated_JJ with_IN
          phosphate_NN buffered_JJ saline_NN (_( PBS_NNP )_) in_IN the_DT absence_NN of_IN labeled_VBN
          SP_NNP conjugate_NN showed_VBD that_IN the_DT transfected_JJ cells_NNS had_VBD some_DT
          intracellular_NN auto-fluorescence_JJ (_( Fig_NNP ._. 3_LS ,_, F_NN )_) ._. The_DT
          fluorophore-treated_JJ cells_NNS also_RB show_VBP some_DT dull_JJ
          intracellular_NN fluorescence_NN ,_, similar_JJ to_TO the_DT
          auto-fluorescence_JJ seen_VBN in_IN the_DT unstained_JJ control_NN cells_NNS ._.
          The_DT intensity_NN of_IN the_DT staining_VBG produced_VBN by_IN the_DT green_JJ
          fluorophores_NNS was_VBD compared_VBN by_IN quantitative_JJ analysis_NN ._. The_DT
          intensities_NNS of_IN the_DT fluorescence_NN after_IN staining_VBG with_IN
          BODIPY_NNP Fl-_NNP SP_NNP ,_, fluorescein-_NN SP_NNP and_CC Oregon_NNP Green_NNP 488_CD -_: SP_NNP were_VBD
          significantly_RB greater_JJR (_( p_NN <_NN 0_CD ._. 0001_CD )_) than_IN the_DT intensity_NN
          of_IN the_DT fluorescence_NN of_IN cells_NNS treated_VBN with_IN Alexa_NNP 488_CD -_: SP_NNP ._.
          Tetramethylrhodamine-_NNP SP_NNP also_RB produced_VBD intense_JJ membrane_NN
          staining_VBG ._. The_DT intensity_NN of_IN the_DT staining_VBG with_IN
          tetramethylrhodamine-_NN SP_NNP could_MD not_RB be_VB directly_RB compared_VBN to_TO
          the_DT others_NNS due_JJ to_TO its_PRP$ different_JJ excitation_NN and_CC emission_NN
          wavelengths_NNS ._.
          The_DT specificity_NN of_IN the_DT fluorescence_NN staining_VBG was_VBD
          revealed_VBN by_IN the_DT finding_VBG that_IN unlabeled_JJ SP_NNP effectively_RB
          prevented_VBD the_DT fluorescent_NN staining_VBG of_IN rSPR-transfected_JJ
          CHO_NNP cells_NNS ._. The_DT fluorescence_NN of_IN these_DT cells_NNS was_VBD similar_JJ to_TO
          that_DT of_IN transfected_JJ cells_NNS incubated_JJ in_IN PBS_NNP alone_RB (_( Fig_NNP ._. 3_LS ,_,
          F_NN )_) in_IN that_IN they_PRP possessed_VBD some_DT intracellular_NN
          auto-fluorescence_JJ but_CC lacked_VBD membrane_NN staining_VBG ._.
          Application_NNP of_IN the_DT labeled_VBN analogs_NNS to_TO untransfected_JJ
          CHO_NNP cells_NNS did_VBD not_RB produce_VB membrane_NN staining_VBG (_( data_NNS not_RB
          shown_VBN )_) ._. Only_RB intracellular_NN auto-fluorescence_JJ ,_, comparable_JJ
          to_TO that_DT observed_VBD with_IN transfected_JJ cells_NNS incubated_JJ with_IN
          PBS_NNP in_IN the_DT absence_NN of_IN labeled_VBN SP_NNP (_( Fig_NNP ._. 3_LS ,_, F_NN )_) ,_, was_VBD seen_VBN in_IN
          cells_NNS lacking_VBG the_DT rSPR_NN ._.
        
        
          SP_NNP receptor_NN binding_JJ
          An_DT important_JJ determinant_NN of_IN the_DT usefulness_NN of_IN the_DT SP_NNP
          conjugates_NNS is_VBZ their_PRP$ ability_NN to_TO bind_NN to_TO and_CC activate_VBP the_DT
          SPR_NNP ._. Therefore_RB ,_, the_DT ability_NN of_IN each_DT of_IN the_DT fluorescent_NN SP_NNP
          analogs_NNS to_TO compete_VB with_IN [_NN 125_CD I_PRP ]_NN SP_NNP binding_VBG to_TO the_DT SPR_NNP was_VBD
          assessed_VBN using_VBG a_DT heterologous_JJ expression_NN system_NN ,_,
          rSPR-expressing_JJ CHO_NNP cells_NNS ._. The_DT results_NNS are_VBP shown_VBN in_IN Fig_NNP ._.
          4_LS ._. The_DT concentration_NN of_IN fluorescent_NN analog_NN required_VBN to_TO
          inhibit_VB the_DT binding_JJ of_IN radiolabeled_JJ SP_NNP by_IN 50_CD %_NN (_( IC_NNP 
          50_CD )_) was_VBD calculated_VBN from_IN the_DT binding_JJ
          studies_NNS ._. The_DT rank_NN order_NN of_IN potency_NN for_IN the_DT competing_VBG
          peptides_NNS was_VBD :_: unlabeled_JJ SP_NNP (_( 2_CD ._. 0_CD nM_NN )_) >_NN
          tetramethylrhodamine-_NN SP_NNP (_( 4_CD ._. 2_LS nM_NN )_) >_NN Oregon_NNP Green_NNP 488_CD -_: SP_NNP
          (_( 6_CD ._. 4_LS nM_NN )_) >_NN BODIPY-SP_NNP (_( 18_CD ._. 0_CD nM_NN )_) >_NN fluorescein-_NN SP_NNP
          (_( 44_CD ._. 5_LS nM_NN )_) >_NN >_NN >_NN Alexa_NNP 488_CD -_: SP_NNP ._. Alexa_NNP 488_CD -_: SP_NNP (_( Fig_NNP ._.
          4_LS ,_, A_DT )_) did_VBD not_RB compete_VB with_IN [_NN 125_CD I_PRP ]_NN SP_NNP for_IN binding_VBG at_IN the_DT
          rSPR_NN ,_, therefore_RB an_DT IC_NNP 
          50_CD value_NN could_MD not_RB be_VB determined_VBN ._.
          Two-way_NNP analysis_NN of_IN variance_NN followed_VBN by_IN
          Student-_NNP Newman-_NNP Keuls_NNP test_NN showed_VBD that_IN there_EX was_VBD a_DT
          dose-dependent_JJ effect_NN (_( p_NN <_NN 0_CD ._. 001_CD )_) on_IN the_DT binding_JJ of_IN
          unlabeled_JJ SP_NNP and_CC the_DT SP_NNP analogs_NNS to_TO the_DT rSPR_NN ._. Statistical_NNP
          analysis_NN also_RB demonstrated_VBD that_IN the_DT competition_NN binding_JJ
          curves_NNS generated_VBN by_IN the_DT SP_NNP conjugates_NNS were_VBD significantly_RB
          different_JJ than_IN the_DT unlabeled_JJ SP_NNP binding_JJ curve_NN (_( p_NN <_NN
          0_CD ._. 001_CD )_) ._. Further_RB analysis_NN showed_VBD that_IN ,_, with_IN the_DT exception_NN
          of_IN the_DT binding_JJ curves_NNS produced_VBN by_IN tetramethylrhodamine-_NN SP_NNP
          and_CC Oregon_NNP Green_NNP 488_CD -_: SP_NNP ,_, a_DT significant_JJ difference_NN was_VBD
          seen_VBN between_IN the_DT binding_JJ curves_NNS of_IN the_DT different_JJ SP_NNP
          conjugates_NNS (_( p_NN <_NN 0_CD ._. 05_CD )_) ._.
        
        
          Calcium_NNP measurements_NNS
          Activation_NNP of_IN the_DT SPR_NNP expressed_VBD in_IN CHO_NNP cells_NNS results_NNS
          in_IN an_DT elevation_NN in_IN intracellular_NN Ca_MD +_NN +_NN [_NN 7_CD ]_NN ._. The_DT
          biological_JJ activity_NN of_IN the_DT SP_NNP conjugates_NNS was_VBD tested_VBN by_IN
          examining_VBG their_PRP$ ability_NN to_TO elicit_NN Ca_MD +_NN +_NN elevations_NNS ._.
          Dose-response_NNP curves_NNS for_IN the_DT labeled_VBN SP_NNP analogs_NNS and_CC for_IN
          unlabeled_JJ SP_NNP to_TO produce_VB an_DT increase_NN in_IN intracellular_NN Ca_MD
          +_NN +_NN in_IN CHO_NNP cells_NNS transfected_JJ with_IN the_DT rSPR_NN are_VBP shown_VBN in_IN
          Fig_NNP ._. 5_LS ._.
          None_NN of_IN the_DT labeled_VBN SP_NNP analogs_NNS produced_VBN Ca_MD
          +_NN +_NN elevations_NNS (_( n_NN =_SYM 3_LS )_) when_WRB added_VBD to_TO untransfected_JJ CHO_NNP
          cells_NNS at_IN a_DT concentration_NN of_IN 10_CD nM_NN (_( data_NNS not_RB shown_VBN )_) ._. When_WRB
          the_DT fluorescent_NN derivatives_NNS were_VBD added_VBN at_IN a_DT concentration_NN
          of_IN 100_CD nM_NN they_PRP produced_VBD an_DT increase_NN in_IN the_DT fluorescence_NN
          signal_NN due_JJ to_TO the_DT inherent_JJ fluorescence_NN of_IN the_DT probes_NNS ._.
          This_DT could_MD also_RB be_VB seen_VBN in_IN the_DT absence_NN of_IN cells_NNS ._. Due_JJ to_TO
          this_DT interference_NN ,_, the_DT activity_NN of_IN the_DT fluorescent_NN probes_NNS
          to_TO produce_VB Ca_MD +_NN +_NN elevations_NNS could_MD not_RB be_VB tested_VBN at_IN
          concentrations_NNS higher_JJR than_IN 10_CD nM_NN ._.
          Alexa_NNP 488_CD -_: SP_NNP produced_VBD the_DT most_RBS prominent_JJ increase_NN in_IN
          non-specific_JJ fluorescence_NN in_IN the_DT absence_NN of_IN cells_NNS ._. When_WRB 1_CD
          nM_NN or_CC 10_CD nM_NN Alexa_NNP 488_CD -_: SP_NNP was_VBD added_VBN the_DT fluorophore_NN
          produced_VBD signals_NNS similar_JJ in_IN intensity_NN to_TO those_DT observed_VBD
          when_WRB this_DT analog_NN was_VBD added_VBN to_TO transfected_JJ or_CC
          untransfected_JJ CHO_NNP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._. To_TO determine_VB if_IN
          Alexa_NNP 488_CD -_: SP_NNP could_MD specifically_RB produce_VB a_DT
          receptor-mediated_JJ Ca_MD +_NN +_NN response_NN ,_, the_DT average_NN of_IN the_DT
          fluorescence_NN signal_NN produced_VBN by_IN Alexa_NNP 488_CD -_: SP_NNP in_IN the_DT
          absence_NN of_IN cells_NNS was_VBD subtracted_VBN from_IN the_DT fluorescent_NN
          signal_NN obtained_VBN when_WRB Alexa_NNP 488_CD -_: SP_NNP was_VBD added_VBN to_TO
          SPR-expressing_NNP CHO_NNP cells_NNS ._. The_DT results_NNS showed_VBD that_IN Alexa_NNP
          488_CD -_: SP_NNP did_VBD not_RB activate_VBP the_DT SPR_NNP to_TO produce_VB a_DT Ca_MD
          +_NN +_NN response_NN ._. However_RB ,_, the_DT other_JJ four_CD SP_NNP analogs_NNS were_VBD able_JJ
          to_TO elicit_NN Ca_MD +_NN +_NN responses_NNS in_IN rSPR-expressing_JJ CHO_NNP
          cells_NNS ._.
          Statistical_NNP analysis_NN ,_, two-way_JJ analysis_NN of_IN variance_NN
          followed_VBN by_IN Student-_NNP Newman-_NNP Keuls_NNP test_NN ,_, demonstrated_VBN that_IN
          unlabeled_JJ SP_NNP and_CC the_DT SP_NNP analogs_NNS ,_, except_IN Alexa_NNP 488_CD -_: SP_NNP ,_,
          elicited_JJ dose-dependent_JJ Ca_MD +_NN +_NN elevations_NNS (_( p_NN <_NN 0_CD ._. 001_CD )_) ._.
          Analysis_NNP also_RB showed_VBD that_IN there_EX was_VBD not_RB a_DT significant_JJ
          difference_NN (_( p_NN >_NN 0_CD ._. 05_CD )_) in_IN Ca_MD +_NN +_NN elevations_NNS generated_VBN by_IN
          unlabeled_JJ SP_NNP or_CC the_DT various_JJ SP_NNP conjugates_NNS ,_, with_IN the_DT
          exception_NN of_IN Alexa_NNP 488_CD -_: SP_NNP which_WDT did_VBD not_RB elicit_NN a_DT calcium_NN
          response_NN ._.
        
        
          Effects_NNPS of_IN SP_NNP analogs_NNS on_IN single_JJ neurons_NNS
          The_DT data_NNS thus_RB far_RB show_VB that_IN the_DT labeled_VBN forms_NNS of_IN SP_NNP ,_,
          with_IN the_DT exception_NN of_IN Alexa_NNP 488_CD -_: SP_NNP ,_, can_MD bind_NN to_TO and_CC
          activate_VBP the_DT receptor_NN in_IN a_DT heterologous_JJ expression_NN
          system_NN ._. It_PRP is_VBZ also_RB of_IN importance_NN to_TO determine_VB the_DT
          activity_NN of_IN the_DT labeled_VBN ligands_NNS in_IN a_DT cell_NN that_WDT
          endogenously_RB expresses_VBZ the_DT SPR_NNP ._. The_DT principal_JJ neurons_NNS of_IN
          bullfrog_NN sympathetic_JJ ganglia_NN express_VBP a_DT SPR_NNP that_WDT has_VBZ been_VBN
          well_RB characterized_VBN with_IN regard_NN to_TO its_PRP$ structure_NN and_CC
          function_NN ._. The_DT bullfrog_NN sympathetic_JJ ganglia_NN SPR_NNP (_( bfSPR_NN )_)
          has_VBZ 69_CD %_NN homology_NN to_TO the_DT rSPR_NN at_IN the_DT amino_JJ acid_NN level_NN ._.
          Perhaps_RB most_RBS importantly_RB ,_, nine_CD of_IN the_DT ten_CD residues_NNS that_WDT
          have_VBP been_VBN demonstrated_VBN to_TO be_VB important_JJ for_IN SP_NNP binding_JJ to_TO
          mammalian_JJ receptors_NNS are_VBP conserved_JJ in_IN the_DT bullfrog_NN
          receptor_NN ._. The_DT effects_NNS of_IN SP_NNP and_CC other_JJ tachykinins_NNS at_IN the_DT
          bfSPR_NN have_VBP been_VBN previously_RB well_RB characterized_VBN [_NN 8_CD ,_, 9_CD ,_, 5_CD ]_NN ._.
          The_DT primary_JJ biological_JJ response_NN following_VBG activation_NN of_IN
          the_DT ganglionic_JJ SPR_NNP is_VBZ inhibition_NN of_IN the_DT M-_NNP type_NN K_NNP
          +_NN current_JJ ,_, I_PRP 
          M_NNP ._.
          SP_NNP produces_VBZ a_DT dose-dependent_JJ inhibition_NN of_IN I_PRP 
          M_NNP [_NN 9_CD ]_NN ._. The_DT responses_NNS of_IN a_DT given_VBN
          neuron_NN to_TO a_DT given_VBN form_NN of_IN labeled_VBN SP_NNP have_VBP been_VBN compared_VBN
          to_TO the_DT responses_NNS of_IN those_DT same_JJ neurons_NNS to_TO unlabeled_JJ SP_NNP at_IN
          a_DT concentration_NN of_IN 100_CD nM_NN (_( Fig_NNP ._. 6_CD )_) ._. At_IN this_DT concentration_NN
          SP_NNP typically_RB elicits_NNS a_DT 70_CD %_NN depression_NN of_IN I_PRP 
          M_NNP ._. BODIPY_NNP Fl-_NNP SP_NNP and_CC Oregon_NNP Green_NNP
          488_CD -_: SP_NNP produced_VBD an_DT inhibition_NN of_IN I_PRP 
          M_NNP similar_JJ to_TO that_DT of_IN unlabeled_JJ SP_NNP ._.
          Fluorescein-_NNP SP_NNP was_VBD variable_JJ in_IN its_PRP$ ability_NN to_TO inhibit_VB the_DT
          current_NN ,_, being_VBG effective_JJ on_IN only_RB two_CD of_IN the_DT four_CD cells_NNS
          tested_VBN ._. At_IN a_DT concentration_NN of_IN 100_CD nM_NN ,_, neither_DT Alexa_NNP
          488_CD -_: SP_NNP nor_CC tetramethylrhodamine-_NN SP_NNP inhibited_VBD I_PRP 
          M_NNP ;_: thus_RB they_PRP were_VBD further_RBR tested_VBN at_IN a_DT
          concentration_NN of_IN 1_CD μM_NN ._. At_IN this_DT concentration_NN
          tetramethylrhodamine-_NN SP_NNP inhibited_VBD I_PRP 
          M_NNP by_IN 57_CD ±_NN 33_CD %_NN ,_, (_( n_NN =_SYM 4_LS )_) ,_, however_RB Alexa_NNP
          488_CD -_: SP_NNP did_VBD not_RB inhibit_VB I_PRP 
          M_NNP ._. Dose-response_NNP curves_NNS for_IN the_DT
          analogs_NNS that_WDT inhibited_VBD I_PRP 
          M_NNP and_CC for_IN unlabeled_JJ SP_NNP are_VBP shown_VBN in_IN
          the_DT plots_NNS in_IN Fig_NNP ._. 6_CD ._. A_DT dose-dependency_JJ was_VBD observed_VBN for_IN
          the_DT effects_NNS of_IN BODIPY_NNP Fl-_NNP SP_NNP ,_, fluorescein-_NN SP_NNP and_CC Oregon_NNP
          Green_NNP 488_CD -_: SP_NNP ._.
        
      
      
        Discussion_NNP
        A_DT number_NN of_IN previous_JJ studies_NNS have_VBP demonstrated_VBN that_IN
        fluorescently_RB labeled_VBN ligands_NNS are_VBP useful_JJ probes_NNS for_IN
        studying_VBG ligand-receptor_JJ interactions_NNS [_NN 10_CD ,_, 11_CD ,_, 12_CD ]_NN ._.
        Improved_JJ fluorophores_NNS ,_, better_JJR optics_NNS and_CC the_DT increased_VBN
        sensitivity_NN of_IN detection_NN systems_NNS have_VBP led_VBN to_TO an_DT increased_VBN
        usage_NN of_IN fluorescently_RB labeled_VBN ligands_NNS ._. It_PRP is_VBZ of_IN vital_JJ
        importance_NN that_IN additions_NNS of_IN fluorescent_NN groups_NNS do_VBP not_RB
        alter_VB the_DT normal_JJ functioning_NN of_IN the_DT ligand_NN ,_, for_IN example_NN ,_, by_IN
        changing_VBG the_DT binding_JJ affinity_NN or_CC by_IN altering_VBG the_DT receptor_NN
        activation_NN properties_NNS of_IN the_DT ligand_NN ._. If_IN the_DT fluorescent_NN
        group_NN does_VBZ alter_VB the_DT properties_NNS of_IN the_DT ligand_NN ,_, it_PRP is_VBZ
        important_JJ that_IN these_DT alterations_NNS be_VB understood_VBN so_IN that_IN the_DT
        results_NNS obtained_VBN with_IN the_DT labeled_VBN ligand_NN can_MD be_VB correctly_RB
        interpreted_VBN ._. In_IN this_DT study_NN ,_, we_PRP have_VBP examined_VBN the_DT
        fundamental_JJ consequences_NNS of_IN labeling_VBG the_DT neuropeptide_NN SP_NNP
        with_IN five_CD different_JJ fluorescent_NN probes_NNS by_IN comparing_VBG the_DT
        effects_NNS of_IN the_DT labeled_VBN compounds_NNS with_IN those_DT of_IN the_DT parent_NN
        compound_NN ,_, SP_NNP ._.
        All_DT five_CD of_IN the_DT fluorescent_NN probes_NNS were_VBD modified_VBN at_IN the_DT
        Lys_NNP 3_CD position_NN with_IN aromatic_JJ groups_NNS ._. Alexa_NNP 488_CD and_CC
        tetramethylrhodamine_NN add_VB negative_JJ and_CC positive_JJ charges_NNS ,_,
        respectively_RB ,_, to_TO SP_NNP ._. The_DT remaining_VBG fluorophores_NNS ,_, BODIPY_NNP Fl_NNP ,_,
        fluorescein_NN and_CC Oregon_NNP Green_NNP 488_CD ,_, do_VBP not_RB alter_VB the_DT charge_NN ._.
        With_IN regard_NN to_TO size_NN ,_, BODIPY_NNP Fl_NNP is_VBZ the_DT smallest_JJS of_IN the_DT
        fluorophores_NNS added_VBD ,_, whereas_IN Alexa_NNP 488_CD and_CC
        tetramethylrhodamine_NN are_VBP the_DT largest_JJS of_IN the_DT
        fluorophores_NNS ._.
        The_DT most_RBS significant_JJ alteration_NN of_IN the_DT activity_NN of_IN SP_NNP
        was_VBD produced_VBN when_WRB Alexa_NNP 488_CD was_VBD added_VBN to_TO SP_NNP ._. The_DT
        experiments_NNS repeatedly_RB showed_VBD that_IN Alexa_NNP 488_CD -_: SP_NNP does_VBZ not_RB
        posses_NNS the_DT same_JJ characteristics_NNS as_IN unlabeled_JJ SP_NNP ._. Alexa_NNP
        488_CD -_: SP_NNP did_VBD not_RB compete_VB with_IN [_NN 125_CD I_PRP ]_NN SP_NNP in_IN the_DT competition_NN
        binding_JJ assay_NN ._. Consistent_NNP with_IN the_DT binding_JJ data_NN ,_, this_DT SP_NNP
        analog_NN did_VBD not_RB stain_VB rSPR-transfected_JJ CHO_NNP cells_NNS ._.
        Furthermore_RB ,_, Alexa_NNP 488_CD -_: SP_NNP did_VBD not_RB exhibit_VB functional_JJ
        activity_NN in_IN two_CD different_JJ assays_NNS ._. It_PRP failed_VBD to_TO elicit_NN a_DT Ca_MD
        +_NN +_NN response_NN in_IN rSPR-expressing_JJ CHO_NNP cells_NNS and_CC failed_VBD to_TO
        produce_VB I_PRP 
        M_NNP inhibition_NN at_IN the_DT bfSPR_NN ,_, both_DT of_IN which_WDT
        are_VBP characteristic_JJ effects_NNS mediated_JJ by_IN SP_NNP ._.
        Like_IN Alexa_NNP 488_CD ,_, tetramethylrhodamine_NN also_RB adds_VBZ a_DT charge_NN
        to_TO SP_NNP ,_, but_CC tetramethylrhodamine-_NN SP_NNP generated_VBD an_DT IC_NNP 
        50_CD that_WDT was_VBD the_DT most_RBS similar_JJ to_TO that_DT of_IN
        unlabeled_JJ SP_NNP ._. This_DT SP_NNP analog_NN also_RB produced_VBD intense_JJ staining_VBG
        and_CC typical_JJ Ca_MD +_NN +_NN responses_NNS at_IN the_DT rSPR_NN ._. However_RB ,_,
        tetramethylrhodamine-_NN SP_NNP was_VBD ineffective_JJ at_IN inhibiting_VBG I_PRP 
        M_NNP at_IN a_DT 100_CD nM_NN concentration_NN ,_, but_CC did_VBD so_RB
        upon_IN increasing_VBG the_DT concentration_NN to_TO 1_CD μM_NN ._. Therefore_RB ,_,
        tetramethylrhodamine-_NN SP_NNP is_VBZ capable_JJ of_IN binding_VBG to_TO the_DT SPR_NNP
        and_CC activating_VBG Ca_MD +_NN +_NN responses_NNS ,_, but_CC has_VBZ a_DT decreased_VBN potency_NN
        for_IN inhibiting_VBG I_PRP 
        M_NNP ._.
        Lys_NNP 3_CD of_IN SP_NNP has_VBZ been_VBN shown_VBN to_TO interact_NN with_IN the_DT NH_NNP 
        2_CD -_: terminal_NN extracellular_NN tail_NN (_( residues_NNS
        1_CD -_: 21_CD )_) of_IN the_DT mouse_NN SPR_NNP [_NN 13_CD ]_NN ._. Though_IN residues_NNS 1_CD -_: 21_CD of_IN the_DT
        mouse_NN SPR_NNP are_VBP primarily_RB conserved_JJ in_IN the_DT rSPR_NN ,_, only_RB 5_CD of_IN
        the_DT 21_CD residues_NNS are_VBP conserved_JJ in_IN the_DT bullfrog_NN SPR_NNP ._. Given_VBN
        the_DT importance_NN of_IN Lys_NNP 3_CD in_IN the_DT mouse_NN SPR_NNP ,_, it_PRP is_VBZ therefore_RB
        conceivable_JJ that_IN an_DT alteration_NN in_IN the_DT charge_NN of_IN the_DT parent_NN
        compound_NN ,_, SP_NNP ,_, as_IN is_VBZ the_DT case_NN with_IN Alexa_NNP 488_CD -_: SP_NNP and_CC
        tetramethylrhodamine-_NN SP_NNP ,_, may_MD cause_VB a_DT change_NN in_IN the_DT typical_JJ
        actions_NNS of_IN SP_NNP ._. The_DT addition_NN of_IN Alexa_NNP 488_CD causes_NNS a_DT greater_JJR
        change_NN in_IN the_DT charge_NN of_IN SP_NNP ,_, which_WDT might_MD inhibit_VB proper_JJ
        ligand-receptor_JJ interaction_NN and_CC thus_RB hinder_VB binding_VBG of_IN the_DT
        SP_NNP analog_NN to_TO the_DT SPR_NNP ._. Tetramethylrhodamine_NNP also_RB alters_NNS the_DT
        charge_NN of_IN SP_NNP ,_, but_CC unlike_IN Alexa_NNP 488_CD ,_, the_DT fluorophore_NN is_VBZ
        positively_RB charged_VBN ._. Perhaps_RB the_DT addition_NN a_DT single_JJ positive_JJ
        charge_NN to_TO SP_NNP by_IN tetramethylrhodamine_NN does_VBZ not_RB disrupt_VB
        proper_JJ ligand_NN /_NN receptor_NN interactions_NNS as_RB drastically_RB as_IN the_DT
        multiple_JJ negative_JJ charges_NNS that_IN Alexa_NNP 488_CD adds_VBZ to_TO SP_NNP ._.
        Therefore_RB ,_, the_DT less_RBR drastic_JJ charge_NN alteration_NN made_VBN by_IN
        tetramethylrhodamine_NN may_MD allow_VB the_DT mechanistic_JJ
        characteristics_NNS of_IN SP_NNP to_TO be_VB preserved_VBN ,_, albeit_IN with_IN a_DT
        decreased_VBN potency_NN to_TO inhibit_VB I_PRP 
        M_NNP ._.
        Although_IN the_DT structure_NN of_IN fluorescein_NN is_VBZ very_RB similar_JJ to_TO
        that_DT of_IN Oregon_NNP Green_NNP 488_CD (_( 2_CD '_POS ,_, 7_CD '_POS -_: difluorofluorescein_NN )_) ,_,
        fluorescein-_NN SP_NNP did_VBD not_RB behave_VB in_IN the_DT same_JJ manner_NN as_IN Oregon_NNP
        Green_NNP 488_CD -_: SP_NNP or_CC unlabeled_JJ SP_NNP ._. Of_IN the_DT conjugates_NNS that_WDT
        competed_VBD with_IN [_NN 125_CD I_PRP ]_NN SP_NNP ,_, fluorescein-_NN SP_NNP had_VBD the_DT lowest_JJS
        binding_JJ affinity_NN as_IN compared_VBN to_TO unlabeled_JJ SP_NNP ._. The_DT analog_NN
        was_VBD also_RB variable_JJ in_IN its_PRP$ ability_NN to_TO inhibit_VB I_PRP 
        M_NNP at_IN the_DT bfSPR_NN ._. However_RB ,_, it_PRP consistently_RB
        produced_VBD Ca_MD +_NN +_NN elevations_NNS and_CC membrane_NN staining_VBG at_IN the_DT rSPR_NN
        expressed_VBD in_IN CHO_NNP cells_NNS ._.
        BODIPY_NNP Fl-_NNP SP_NNP and_CC Oregon_NNP Green_NNP 488_CD -_: SP_NNP produced_VBD inhibition_NN
        of_IN I_PRP 
        M_NNP and_CC Ca_MD +_NN +_NN elevations_NNS similar_JJ to_TO that_DT
        produced_VBN by_IN unlabeled_JJ SP_NNP ._. Thus_RB ,_, labeling_VBG with_IN either_DT of_IN
        these_DT two_CD fluorophores_NNS did_VBD not_RB alter_VB the_DT functional_JJ
        activity_NN of_IN SP_NNP at_IN the_DT SPR_NNP in_IN either_DT a_DT heterologous_JJ
        expression_NN system_NN or_CC native_JJ cells_NNS ._. These_DT SP_NNP analogs_NNS also_RB
        brightly_RB stained_JJ the_DT membranes_NNS of_IN rSPR_NN transfected_JJ CHO_NNP
        cells_NNS ._. The_DT IC_NNP 
        50_CD values_NNS of_IN BODIPY_NNP Fl-_NNP SP_NNP and_CC Oregon_NNP
        Green_NNP 488_CD -_: SP_NNP in_IN competition_NN binding_JJ studies_NNS were_VBD greater_JJR
        than_IN that_DT of_IN unlabeled_JJ SP_NNP ._. When_WRB compared_VBN to_TO unlabeled_JJ SP_NNP ,_,
        Oregon_NNP Green_NNP 488_CD -_: SP_NNP and_CC BODIPY_NNP FL-SP_NNP had_VBD a_DT two-fold_JJ and_CC
        ten-fold_JJ increase_NN in_IN binding_JJ affinity_NN ,_, respectively_RB ._.
        Interestingly_RB ,_, neither_DT BODIPY_NNP Fl_NNP nor_CC Oregon_NNP Green_NNP 488_CD is_VBZ
        charged_VBN ._.
        It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN although_IN there_EX was_VBD a_DT
        significant_JJ difference_NN between_IN the_DT binding_JJ curves_NNS of_IN the_DT
        fluorescent_NN derivatives_NNS of_IN SP_NNP and_CC unlabeled_JJ SP_NNP ,_, there_EX was_VBD
        not_RB a_DT statistically_RB significant_JJ in_IN the_DT peptides_NNS '_POS ability_NN to_TO
        produce_VB dose-dependent_JJ Ca_MD +_NN +_NN elevations_NNS ._. These_DT might_MD be_VB
        explained_VBN by_IN the_DT differences_NNS in_IN the_DT mechanisms_NNS that_WDT
        underlie_VB the_DT measurements_NNS made_VBN in_IN the_DT different_JJ
        experiments_NNS ._. The_DT binding_JJ experiments_NNS measure_NN the_DT actions_NNS of_IN
        the_DT peptides_NNS at_IN the_DT receptor_NN ._. Ca_MD +_NN +_NN fluxes_NNS indicate_VBP
        additional_JJ mechanisms_NNS downstream_JJ of_IN the_DT receptor_NN ,_, including_VBG
        second_JJ messenger_NN activation_NN ._. The_DT data_NNS may_MD reflect_VB the_DT fact_NN
        that_DT receptor_NN binding_JJ and_CC signal_NN activation_NN are_VBP not_RB
        strictly_RB correlated_JJ in_IN G-_NNP protein_NN coupled_VBN systems_NNS ._.
        The_DT evidence_NN presented_VBN here_RB suggests_VBZ that_IN four_CD of_IN the_DT
        analogs_NNS ,_, BODIPY_NNP Fl-_NNP SP_NNP ,_, fluorescein-_NN SP_NNP ,_, Oregon_NNP Green_NNP 488_CD -_: SP_NNP
        and_CC tetramethylrhodamine-_NN SP_NNP ,_, are_VBP acting_VBG specifically_RB at_IN the_DT
        SPR_NNP ._. Binding_NNP analysis_NN showed_VBD that_IN the_DT above_JJ conjugates_NNS
        compete_VBP with_IN [_NN 125_CD I_PRP ]_NN SP_NNP at_IN the_DT rSPR_NN ._. These_DT four_CD analogs_NNS
        only_RB produced_VBN Ca_MD +_NN +_NN responses_NNS in_IN cells_NNS transfected_JJ with_IN the_DT
        SPR_NNP ;_: they_PRP had_VBD no_DT effect_NN in_IN non-transfected_JJ cells_NNS ._.
        Similarly_RB ,_, membrane_NN staining_VBG was_VBD observed_VBN in_IN transfected_JJ
        CHO_NNP cells_NNS ,_, but_CC not_RB in_IN untransfected_JJ cells_NNS ._.
        Molecular_NNP Probes_NNP introduced_VBD and_CC investigated_VBN seven_CD Alexa_NNP
        dyes_NNS ,_, including_VBG Alexa_NNP 488_CD ,_, and_CC reported_VBD that_IN the_DT dyes_NNS were_VBD
        more_JJR fluorescent_NN and_CC more_RBR photostable_JJ than_IN their_PRP$
        counterparts_NNS [_NN 14_CD ]_NN ._. In_IN their_PRP$ study_NN ,_, Alexa_NNP 488_CD was_VBD compared_VBN
        to_TO fluorescein_NN ._. The_DT investigators_NNS conjugated_JJ the_DT Alexa_NNP
        fluorophores_NNS and_CC other_JJ similar_JJ compounds_NNS ,_, such_JJ as_IN
        fluorescein_NN ,_, to_TO different_JJ proteins_NNS to_TO compare_VB brightness_NNS
        and_CC stability_NN ._. They_PRP showed_VBD that_IN Alexa_NNP 488_CD was_VBD brighter_JJR and_CC
        more_RBR stable_JJ than_IN fluorescein_NN when_WRB conjugated_JJ to_TO biotin_NN
        binding_JJ proteins_NNS ,_, goat_NN anti-mouse_JJ IgG_NNP and_CC its_PRP$ F_NN (_( ab_NN '_'' )_) 2_CD
        fragments_NNS ._. However_RB ,_, they_PRP did_VBD not_RB test_VB for_IN alterations_NNS in_IN
        binding_JJ affinities_NNS or_CC biological_JJ activity_NN after_IN the_DT
        addition_NN of_IN the_DT fluorophores_NNS ._.
        Another_DT study_NN has_VBZ examined_VBN the_DT effects_NNS of_IN fluorescent_NN
        conjugation_NN on_IN opioid_NN peptide_NN activity_NN [_NN 15_CD ]_NN ._. Alexa_NNP 488_CD and_CC
        BODIPY_NNP TR_NNP were_VBD used_VBN to_TO label_VB dermorphin_NN ,_, deltrophin_NN ,_, TIPP_NNP
        (_( Try-_NNP Tic-_NNP Phe-_NNP Phe_NNP )_) and_CC endomorphin_NN by_IN adding_VBG a_DT cysteine_NN to_TO
        each_DT peptide_NN at_IN the_DT C-_NNP terminus_JJ ,_, followed_VBN by_IN conjugation_NN of_IN
        the_DT fluorophores_NNS to_TO the_DT cysteine_NN residue_NN ._. The_DT investigators_NNS
        found_VBD that_IN the_DT dermorphin_NN and_CC deltorphin_NN analogs_NNS had_VBD an_DT
        increased_VBN binding_JJ affinity_NN for_IN the_DT μ-_NN and_CC δ-opioid_JJ
        receptors_NNS ,_, respectively_RB ,_, and_CC that_IN the_DT biological_JJ activities_NNS
        of_IN parent_NN compounds_NNS were_VBD preserved_VBN ._. However_RB ,_, when_WRB Alexa_NNP 488_CD
        was_VBD conjugated_JJ to_TO TIPP_NNP and_CC endomorphin_NN ,_, the_DT binding_JJ
        affinities_NNS of_IN the_DT parent_NN compounds_NNS were_VBD decreased_VBN ._.
        Buku_NNP et_CC al_NN ._. [_NN 16_CD ]_NN synthesized_JJ two_CD fluorescent_NN probes_NNS for_IN
        the_DT vasotocin_NN receptor_NN using_VBG fluorescein_NN and_CC
        tetramethylrhodamine_NN ._. These_DT investigators_NNS had_VBD previously_RB
        conjugated_JJ the_DT fluorophores_NNS to_TO the_DT seventh_JJ position_NN of_IN
        vasotocin_NN ,_, a_DT nonapeptide_NN ,_, and_CC found_VBD that_IN it_PRP had_VBD biological_JJ
        activity_NN ,_, but_CC that_IN the_DT biological_JJ activity_NN was_VBD reduced_VBN when_WRB
        compared_VBN to_TO the_DT native_JJ compound_NN [_NN 17_CD ]_NN ._. Therefore_RB ,_, the_DT
        investigators_NNS conjugated_JJ the_DT fluorophores_NNS to_TO the_DT ninth_JJ
        position_NN and_CC found_VBD that_IN the_DT analog_NN was_VBD 10_CD -_: fold_VB more_RBR potent_JJ
        than_IN the_DT analog_NN with_IN the_DT fluorophores_NNS at_IN the_DT seventh_JJ
        position_NN ._. Thus_RB ,_, they_PRP concluded_VBD that_IN by_IN moving_VBG the_DT bulky_JJ
        fluorophore_NN to_TO the_DT end_NN of_IN vasotocin_NN ,_, and_CC not_RB altering_VBG an_DT
        amino_JJ acid_NN involved_VBN in_IN binding_JJ and_CC activation_NN of_IN the_DT
        vasotocin_NN receptor_NN minimized_VBN the_DT reduction_NN in_IN biological_JJ
        activity_NN of_IN the_DT probes_NNS ._.
        In_IN summary_NN ,_, our_PRP$ results_NNS along_IN with_IN those_DT from_IN other_JJ labs_NNS
        show_VBP that_IN ,_, in_IN some_DT cases_NNS ,_, conjugation_NN of_IN a_DT specific_JJ
        fluorescent_NN label_NN can_MD be_VB added_VBN to_TO a_DT peptide_NN without_IN
        altering_VBG the_DT activity_NN of_IN the_DT parent_NN compound_NN ._. In_IN other_JJ
        cases_NNS ,_, however_RB ,_, the_DT activity_NN of_IN the_DT original_JJ compound_NN may_MD
        be_VB drastically_RB altered_VBN ._. Therefore_RB ,_, the_DT biological_JJ activity_NN
        of_IN each_DT novel_NN fluorophore_NN conjugate_NN must_MD be_VB analyzed_VBN ._.
        Analysis_NNP of_IN labeled_VBN compounds_NNS should_MD include_VB assessment_NN of_IN
        binding_JJ and_CC biological_JJ activity_NN as_RB well_RB as_IN brightness_NNS and_CC
        stability_NN ._.
      
      
        Conclusions_NNP
        The_DT results_NNS of_IN our_PRP$ study_NN show_NN that_IN there_EX are_VBP dramatic_JJ
        differences_NNS in_IN the_DT function_NN of_IN SP_NNP labeled_VBD at_IN the_DT Lys_NNP
        3_CD position_NN with_IN different_JJ fluorophores_NNS ._. Alexa_NNP 488_CD ,_, which_WDT was_VBD
        the_DT largest_JJS and_CC added_VBD the_DT most_RBS charged_VBN groups_NNS to_TO SP_NNP ,_, was_VBD
        unable_JJ to_TO label_VB the_DT SPR_NNP and_CC altered_VBD the_DT biological_JJ activity_NN
        of_IN SP_NNP in_IN live_VB and_CC cultured_JJ cells_NNS ._. Oregon_NNP Green_NNP 488_CD and_CC
        BODIPY_NNP Fl_NNP ,_, which_WDT are_VBP smaller_JJR and_CC uncharged_JJ ,_, appear_VB to_TO be_VB
        the_DT most_RBS useful_JJ fluorophores_NNS for_IN labeling_VBG SP_NNP without_IN
        altering_VBG the_DT normal_JJ functions_NNS of_IN SP_NNP at_IN the_DT SPR_NNP regardless_RB
        of_IN the_DT expression_NN system_NN ._. These_DT results_NNS suggest_VBP that_IN Oregon_NNP
        Green_NNP 488_CD -_: SP_NNP and_CC BODIPY_NNP Fl-_NNP SP_NNP would_MD be_VB the_DT most_RBS useful_JJ
        fluorescent_NN ligands_NNS for_IN future_JJ studies_NNS of_IN the_DT SPR_NNP ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Labeled_NNP peptides_NNS
          SP_NNP labeled_VBD with_IN Alexa_NNP 488_CD (_( S-_NNP 13426_CD )_) ,_, BODIPY_NNP Fl_NNP
          (_( S-_NNP 13425_CD )_) ,_, fluorescein_NN (_( S-_NNP 13424_CD )_) ,_, Oregon_NNP Green_NNP 488_CD
          (_( S-_NNP 13427_CD )_) or_CC tetramethylrhodamine_NN (_( S-_NNP 13428_CD )_) on_IN Lys_NNP 3_CD were_VBD
          purchased_VBN from_IN Molecular_NNP Probes_NNP (_( Eugene_NNP ,_, OR_NNP )_) ,_, product_NN
          numbers_NNS in_IN parenthesis_NNS ._. The_DT chemical_NN formulae_NN for_IN the_DT
          labeled_VBN compounds_NNS are_VBP shown_VBN in_IN Fig_NNP ._. 1_LS ._.
        
        
          Spectra_NNP
          Fluorophore_NNP spectral_NN analysis_NN was_VBD performed_VBN on_IN a_DT
          Perkin_NNP Elmer_NNP 512_CD Spectrofluorometer_NNP (_( Foster_NNP City_NNP ,_, CA_NNP )_) ._.
          Alexa_NNP 488_CD -_: SP_NNP ,_, BODIPY_NNP Fl-_NNP SP_NNP ,_, fluorescein-_NN SP_NNP ,_, Oregon_NNP Green_NNP
          488_CD -_: SP_NNP and_CC tetramethylrhodamine-_NN SP_NNP were_VBD analyzed_VBN at_IN a_DT
          concentration_NN of_IN 10_CD nM_NN ,_, using_VBG PBS_NNP ,_, pH_NN 7_CD ._. 4_CD ,_, as_IN a_DT
          solvent_JJ ._.
        
        
          Epifluorescence_NNP microscopy_NN
          CHO_NNP cells_NNS stably_RB transfected_JJ with_IN the_DT cDNA_NN of_IN the_DT rSPR_NN
          were_VBD obtained_VBN from_IN Dr_NNP ._. James_NNP Krause_NNP and_CC maintained_VBN as_RB
          previously_RB described_VBD [_NN 18_CD ]_NN ._. Transfected_NNP CHO_NNP cells_NNS were_VBD
          cultured_JJ overnight_JJ on_IN 3_CD -_: well_RB HTC_NNP super_JJ cured_VBN glass_NN slides_NNS
          (_( Cel-_NNP Line_NNP Associates_NNPS ,_, Inc_NNP ._. ,_, Newfield_NNP ,_, NJ_NNP )_) ._. The_DT following_VBG
          day_NN ,_, the_DT slides_NNS were_VBD rinsed_JJ with_IN PBS_NNP ._. Two_CD of_IN the_DT three_CD
          wells_NNS from_IN each_DT slide_NN were_VBD stained_JJ with_IN 100_CD nM_NN of_IN one_CD of_IN
          the_DT SP_NNP conjugates_NNS ._. The_DT third_NN well_RB of_IN each_DT slide_NN served_VBD as_IN
          a_DT negative_JJ control_NN ,_, in_IN that_IN the_DT cells_NNS were_VBD incubated_JJ with_IN
          PBS_NNP in_IN the_DT absence_NN of_IN a_DT SP_NNP analog_NN ._. Slides_NNS were_VBD incubated_JJ
          for_IN 2_CD hrs_NNS at_IN 4_CD °_NN C_NNP ,_, to_TO prevent_VB internalization_NN of_IN the_DT
          receptor_NN and_CC thus_RB provide_VB membrane_NN staining_VBG ._. The_DT cells_NNS
          were_VBD then_RB rinsed_JJ and_CC fixed_VBN with_IN paraformaldehyde_NN (_( 2_CD %_NN )_)
          (_( Fisher_NNP Scientific_NNP ,_, Pittsburgh_NNP ,_, PA_NNP )_) at_IN 4_CD °_NN C_NNP for_IN 20_CD min_NN ._.
          Slides_NNS were_VBD viewed_VBN under_IN a_DT Nikon_NNP Eclipse_NNP E_NNP 600_CD FN_NNP
          fluorescent_NN microscope_NN (_( Fryer_NNP Company_NNP ,_, Inc_NNP ._. ,_, Cincinnati_NNP ,_,
          OH_NNP )_) ._. The_DT green_JJ fluorophores_NNS were_VBD excited_VBN using_VBG a_DT FITC_NNP
          (_( fluorescein_NN isothiocyanate_NN )_) filter_NN set_VBN (_( excitation_NN
          465_CD -_: 495_CD nm_NN ,_, dichroic_JJ 505_CD LP_NNP ,_, emission_NN 515_CD -_: 555_CD nm_NN )_) ._. The_DT red_JJ
          fluorophore_NN was_VBD excited_VBN using_VBG a_DT TRITC_NNP
          (_( tetramethylrhodamine_NN isothiocyanate_NN )_) filter_NN set_VBN
          (_( excitation_NN 528_CD -_: 553_CD nm_NN ,_, dichroic_JJ 565_CD LP_NNP ,_, emission_NN 600_CD -_: 660_CD
          nm_NN )_) ._. Pictures_NNP were_VBD taken_VBN with_IN a_DT SPOT_NNP camera_NN (_( Diagnostic_NNP
          Instruments_NNP ,_, Inc_NNP ._. ,_, Sterling_NNP Heights_NNP ,_, MI_NNP )_) ._. All_DT digital_JJ
          images_NNS of_IN the_DT green_JJ fluorophores_NNS were_VBD taken_VBN at_IN a_DT constant_JJ
          gain_NN (_( 16_CD )_) and_CC exposure_NN time_NN (_( 0_CD ._. 7_CD s_VBZ )_) to_TO allow_VB for_IN direct_JJ
          comparison_NN between_IN cells_NNS and_CC experiments_NNS ._. Pictures_NNS of_IN
          tetramethylrhodamine-_NN SP_NNP ,_, the_DT red_JJ fluorophore_NN ,_, were_VBD taken_VBN
          at_IN a_DT gain_NN of_IN 8_CD and_CC a_DT 0_CD ._. 4_CD s_VBZ exposure_NN time_NN ._.
          The_DT specificity_NN of_IN the_DT fluorescent_NN staining_VBG to_TO the_DT
          rSPR_NN was_VBD analyzed_VBN in_IN two_CD ways_NNS ._. First_LS ,_, incubating_VBG
          untransfected_JJ CHO_NNP cells_NNS with_IN 100_CD nM_NN of_IN each_DT analog_NN
          assessed_VBD non-specific_JJ staining_VBG ._. Secondly_RB ,_, staining_VBG of_IN
          rSPR-transfected_JJ CHO_NNP cells_NNS was_VBD performed_VBN in_IN the_DT presence_NN
          of_IN an_DT excess_NN of_IN unlabeled_JJ SP_NNP ._. Transfected_NNP cells_NNS were_VBD
          pretreated_JJ with_IN 1_CD μM_NN unlabeled_JJ SP_NNP for_IN 1_CD hr_NN at_IN 4_CD °_NN C_NNP ._. Then_RB ,_,
          the_DT cells_NNS were_VBD rinsed_JJ and_CC incubated_JJ with_IN 1_CD μM_NN unlabeled_JJ
          SP_NNP and_CC 100_CD nM_NN labeled_VBD SP_NNP for_IN 1_CD hr_NN at_IN 4_CD °_NN C_NNP ._. The_DT cells_NNS were_VBD
          rinsed_JJ ,_, fixed_VBN and_CC viewed_VBN as_IN described_VBN above_IN ._.
        
        
          Image_NN Analysis_NNP
          Epifluorescence_NNP images_NNS from_IN the_DT wells_NNS containing_VBG only_RB
          conjugated_JJ SP_NNP (_( 100_CD nM_NN )_) were_VBD analyzed_VBN using_VBG Scion_NNP Image_NN
          (_( Scion_NNP Corporation_NNP ,_, Frederick_NNP ,_, MD_NNP )_) ._. For_IN each_DT fluorophore_NN ,_,
          except_IN tetramethylrhodamine_NN ,_, a_DT line_NN was_VBD drawn_VBN around_IN the_DT
          outside_JJ of_IN the_DT cell_NN membrane_NN of_IN 10_CD cells_NNS (_( 5_CD
          cells_NNS /_NN experiment_NN )_) to_TO create_VB a_DT boundary_NN ;_: the_DT area_NN and_CC
          pixel_NN intensity_NN were_VBD then_RB measured_VBN within_IN each_DT boundary_NN ._.
          Background_NNP ,_, as_IN determined_VBN by_IN measuring_VBG the_DT intensity_NN and_CC
          area_NN of_IN 10_CD control_NN cells_NNS incubated_JJ with_IN PBS_NNP in_IN the_DT
          absence_NN of_IN a_DT fluorophore_NN ,_, was_VBD subtracted_VBN ._. Cell_NNP area_NN was_VBD
          used_VBN to_TO normalize_VB between_IN cells_NNS ,_, thus_RB the_DT ratio_NN of_IN
          intensity_NN to_TO area_NN was_VBD calculated_VBN for_IN the_DT treated_VBN and_CC
          untreated_JJ cells_NNS ._.
        
        
          Receptor_NNP binding_JJ
          Radioligand_NNP competition_NN binding_JJ assays_NNS utilizing_VBG CHO_NNP
          cells_NNS stably_RB expressing_VBG the_DT rSPR_NN were_VBD performed_VBN with_IN
          Bolton-_NNP Hunter_NNP [_NN 125_CD I_PRP ]_NN SP_NNP (_( NEN_NNP ,_, Boston_NNP ,_, MA_NNP )_) at_IN a_DT
          concentration_NN of_IN 50_CD pM_NN ._. Fluorescein-_NNP SP_NNP ,_, Alexa_NNP 488_CD -_: SP_NNP ,_,
          BODIPY_NNP Fl-_NNP SP_NNP ,_, fluorescein-_NN SP_NNP ,_, Oregon_NNP Green_NNP 488_CD -_: SP_NNP or_CC
          tetramethylrhodamine-_NN SP_NNP was_VBD added_VBN at_IN increasing_VBG
          concentrations_NNS ,_, from_IN 100_CD pM_NN to_TO 1_CD μM_NN ,_, to_TO compete_VB with_IN the_DT
          [_NN 125_CD I_PRP ]_NN SP_NNP ._. In_IN order_NN to_TO reach_VB equilibrium_NN ,_,
          rSPR-expressing_JJ CHO_NNP cells_NNS (_( 100_CD ,_, 000_CD cells_NNS /_NN well_RB )_) were_VBD
          incubated_JJ in_IN a_DT pre-wetted_JJ Millipore_NNP Multiscreen_NNP 96_CD well_RB
          BV_NNP filtration_NN plate_NN (_( France_NNP )_) with_IN both_DT radiolabeled_JJ and_CC
          fluorescently_RB labeled_VBN SP_NNP at_IN 4_CD °_NN C_NNP for_IN 2_CD hrs_NNS ._. Peptides_NNP and_CC
          cells_NNS were_VBD prepared_VBN in_IN Tris_NNP Buffered_NNP Saline_NNP Binding_NNP
          Buffer_NNP :_: 50_CD mM_NN Tris_NNP ,_, 120_CD mM_NN NaCl_NNP ,_, 0_CD ._. 2_CD mg_NN /_NN ml_NN bacitracin_NN ,_, 20_CD
          μg_NN /_NN ml_NN leupeptin_NN ,_, 20_CD μg_NN /_NN ml_NN chymostatin_NN ,_, 0_CD ._. 1_CD %_NN bovine_JJ serum_NN
          albumin_NN ,_, pH_NN 7_CD ._. 4_CD ._. Following_VBG incubation_NN ,_, cells_NNS were_VBD
          filtered_VBN and_CC washed_VBN using_VBG a_DT Millipore_NNP vacuum_NN manifold_NN
          (_( France_NNP )_) ._. Filters_NNP were_VBD punched_VBN and_CC analyzed_VBD using_VBG a_DT
          Packard_NNP Cobra_NNP II_NNP series_NN auto-gamma_JJ counter_NN (_( Meriden_NNP ,_, CT_NNP )_)
          to_TO determine_VB counts_VBZ per_IN minute_NN (_( cpm_NN )_) ._.
          Non-specific_NNP binding_JJ was_VBD specified_VBN as_IN the_DT counts_NNS
          obtained_VBN with_IN 1_CD μM_NN unlabeled_JJ SP_NNP in_IN the_DT presence_NN of_IN
          radiolabeled_JJ SP_NNP ._. Statistical_NNP analysis_NN showed_VBD that_IN there_EX
          was_VBD not_RB a_DT significant_JJ difference_NN between_IN the_DT fluorescent_NN
          conjugates_NNS and_CC unlabeled_JJ SP_NNP when_WRB 1_CD μM_NN of_IN SP_NNP or_CC its_PRP$
          derivatives_NNS was_VBD present_JJ with_IN 50_CD pM_NN [_NN 125_CD I_PRP ]_NN SP_NNP ._. In_IN each_DT
          experiment_NN ,_, specific_JJ binding_JJ was_VBD determined_VBN by_IN
          subtracting_VBG nonspecific_JJ binding_VBG from_IN the_DT original_JJ cpm_NN
          measurements_NNS ._. The_DT data_NNS were_VBD normalized_JJ by_IN calculating_VBG B_NN /_NN B_NNP
          
          o_NN for_IN each_DT fluorophore_NN ,_, where_WRB B_NNP is_VBZ the_DT
          cpm_NN of_IN [_NN 125_CD I_PRP ]_NN SP_NNP specifically_RB bound_VBN in_IN the_DT presence_NN of_IN
          non-radioactive_JJ SP_NNP and_CC B_NNP 
          o_NN is_VBZ the_DT cpm_NN of_IN [_NN 125_CD I_PRP ]_NN SP_NNP
          specifically_RB bound_VBN in_IN the_DT presence_NN of_IN 100_CD pM_NN
          fluorescently_RB labeled_VBD SP_NNP ._. The_DT data_NNS were_VBD plotted_VBD as_IN a_DT
          function_NN of_IN competitor_NN concentration_NN vs_NNS ._. B_NN /_NN B_NNP 
          o_NN ._. Sigmoidal_NNP (_( Hill_NNP ,_, 3_CD parameter_NN )_)
          regression_NN was_VBD then_RB performed_VBN on_IN the_DT data_NNS to_TO determine_VB
          the_DT IC_NNP 
          50_CD ,_, the_DT concentration_NN of_IN fluorescent_NN
          analog_NN required_VBN to_TO inhibit_VB the_DT binding_JJ of_IN radiolabeled_JJ SP_NNP
          by_IN 50_CD %_NN ,_, for_IN each_DT SP_NNP analog_NN ._.
        
        
          Calcium_NNP measurements_NNS
          Dose-response_NNP curves_NNS for_IN the_DT ability_NN of_IN the_DT SP_NNP analogs_NNS
          to_TO produce_VB Ca_MD +_NN +_NN elevations_NNS upon_IN binding_VBG to_TO the_DT SPR_NNP were_VBD
          obtained_VBN as_RB previously_RB described_VBD [_NN 5_CD ]_NN ._. Briefly_NNP ,_,
          transfected_JJ CHO_NNP cells_NNS expressing_VBG the_DT rSPR_NN were_VBD cultured_JJ
          onto_IN coverslips_NNS until_IN ∼_NN 90_CD %_NN confluent_NN ._. The_DT coverslips_NNS
          were_VBD incubated_JJ in_IN a_DT Ca_MD +_NN +_NN -_: free_JJ solution_NN containing_VBG
          fura-_NN PE_NNP 3_CD (_( AM_NNP )_) and_CC pluronic_JJ acid_NN (_( Texas_NNP Fluorescence_NNP Labs_NNPS ,_,
          Austin_NNP ,_, TX_NNP )_) for_IN 30_CD min_NN ._. ,_, washed_VBN ,_, then_RB incubated_JJ in_IN a_DT Ca_MD
          +_NN +_NN -_: containing_VBG solution_NN for_IN 30_CD min_NN ._. A_DT CAF-_NNP 110_CD
          Intracellular_NNP Ion_NNP Analyzer_NNP (_( Jasco_NNP Corp_NNP ._. ,_, Tokyo_NNP ,_, Japan_NNP )_)
          was_VBD used_VBN to_TO measure_VB the_DT fura-_NN PE_NNP 3_CD fluorescence_NN emission_NN ._.
          Cytosolic_NNP Ca_NNP +_NN +_NN concentrations_NNS were_VBD measured_VBN by_IN taking_VBG the_DT
          ratio_NN of_IN fluorescence_NN emission_NN at_IN 510_CD nm_NN by_IN excitation_NN at_IN
          340_CD and_CC 380_CD nm_NN ._. Dose-response_NNP curves_NNS were_VBD obtained_VBN by_IN
          measuring_VBG the_DT Ca_MD +_NN +_NN responses_NNS produced_VBN by_IN adding_VBG various_JJ
          concentrations_NNS (_( 1_CD pM_NN ,_, 100_CD nM_NN ,_, 1_CD nM_NN and_CC 10_CD nM_NN )_) of_IN the_DT
          labeled_VBN probes_NNS ._. Ionomycin_NNP (_( Sigma_NNP ,_, St_NNP ._. Louis_NNP ,_, MO_NNP )_) was_VBD
          added_VBN at_IN a_DT concentration_NN of_IN 10_CD μM_NN at_IN the_DT end_NN of_IN each_DT
          experiment_NN to_TO obtain_VB the_DT maximal_NN Ca_MD +_NN +_NN elevation_NN for_IN that_DT
          coverslip_NN ._. Ca_MD +_NN +_NN responses_NNS were_VBD measured_VBN by_IN subtracting_VBG
          the_DT peak_NN of_IN each_DT response_NN from_IN the_DT baseline_NN ._. Responses_NNS
          are_VBP expressed_VBN as_IN a_DT fraction_NN of_IN the_DT ionomycin_NN (_( maximum_NN )_)
          response_NN ._.
          Two_CD experiments_NNS were_VBD carried_VBN out_IN to_TO serve_VB as_IN negative_JJ
          controls_NNS ._. In_IN the_DT first_JJ control_NN experiment_NN ,_, untransfected_JJ
          CHO_NNP cells_NNS were_VBD utilized_JJ to_TO determine_VB if_IN any_DT of_IN the_DT SP_NNP
          conjugates_NNS were_VBD eliciting_VBG Ca_MD +_NN +_NN responses_NNS through_IN a_DT
          pathway_NN independent_JJ of_IN rSPR_NN activation_NN ._. Each_DT of_IN the_DT SP_NNP
          isoforms_NNS was_VBD added_VBN to_TO untransfected_JJ CHO_NNP cells_NNS at_IN a_DT
          concentration_NN of_IN 10_CD nM_NN and_CC the_DT signals_NNS ,_, if_IN any_DT ,_, were_VBD
          recorded_VBN ._. If_IN a_DT SP_NNP conjugate_NN caused_VBD an_DT increase_NN in_IN Ca_MD +_NN +_NN at_IN
          10_CD nM_NN ,_, then_RB 0_CD ._. 1_CD and_CC 1_CD nM_NN concentrations_NNS for_IN that_DT
          fluorophore_NN were_VBD also_RB tested_VBN ._.
          The_DT second_JJ control_NN experiment_NN measured_VBD fluorescence_NN
          produced_VBN by_IN the_DT SP_NNP analogs_NNS themselves_PRP ,_, in_IN the_DT absence_NN of_IN
          cells_NNS ._. Each_DT of_IN the_DT SP_NNP fluorophores_NNS was_VBD added_VBN to_TO the_DT Ca_MD
          +_NN +_NN solution_NN in_IN the_DT absence_NN of_IN cells_NNS at_IN a_DT concentration_NN of_IN
          10_CD nM_NN and_CC increases_NNS in_IN fluorescence_NN ,_, if_IN any_DT ,_, were_VBD
          recorded_VBN ._. If_IN a_DT response_NN was_VBD observed_VBN at_IN a_DT 10_CD nM_NN
          concentration_NN ,_, then_RB 0_CD ._. 1_CD and_CC 1_CD nM_NN concentrations_NNS were_VBD also_RB
          tested_VBN for_IN that_DT SP_NNP analog_NN ._. If_IN a_DT SP_NNP analog_NN produced_VBD a_DT Ca_MD
          +_NN +_NN elevation_NN in_IN either_DT control_NN assay_NN ,_, then_RB the_DT average_JJ (_( n_NN
          of_IN 3_LS )_) for_IN the_DT differences_NNS between_IN the_DT baseline_NN and_CC peak_NN
          Ca_MD +_NN +_NN signals_NNS for_IN that_DT concentration_NN was_VBD calculated_VBN ._. The_DT
          average_NN was_VBD then_RB subtracted_VBN from_IN the_DT Ca_MD +_NN +_NN responses_NNS
          observed_VBD when_WRB that_IN SP_NNP analog_NN was_VBD added_VBN to_TO transfected_JJ and_CC
          untransfected_JJ CHO_NNP cells_NNS at_IN that_DT concentration_NN ._.
        
        
          Electrophysiology_NNP
          Single_NNP neurons_NNS were_VBD dissociated_JJ from_IN bullfrog_NN
          sympathetic_JJ ganglia_NN as_IN described_VBN previously_RB [_NN 19_CD ]_NN ._.
          Briefly_NNP ,_, ganglia_NN were_VBD dissected_VBN ,_, treated_VBN with_IN enzymes_NNS and_CC
          then_RB stored_VBD in_IN growth_NN medium_NN at_IN 4_CD °_NN C_NNP for_IN 1_CD to_TO 3_CD days_NNS ._. The_DT
          ganglia_NN were_VBD triturated_JJ to_TO release_VB single_JJ neurons_NNS for_IN
          daily_JJ use_NN ._.
          Whole_JJ cell_NN recordings_NNS of_IN isolated_VBN neurons_NNS were_VBD
          conducted_VBN at_IN room_NN temperature_NN ,_, ∼_NN 21_CD °_NN C_NNP ._. Drugs_NNS were_VBD applied_VBN
          by_IN single_JJ cell_NN superfusion_NN [_NN 20_CD ]_NN and_CC the_DT bath_NN constantly_RB
          perfused_JJ separately_RB with_IN extracellular_NN solution_NN ._. Whole_JJ
          cell_NN recordings_NNS were_VBD made_VBN with_IN electrodes_NNS with_IN
          resistances_NNS of_IN 0_CD ._. 25_CD -_: 1_CD MΩ_NNP when_WRB filled_VBN with_IN intracellular_NN
          solution_NN ._.
          The_DT compositions_NNS of_IN solutions_NNS for_IN electrophysiology_NN
          are_VBP shown_VBN in_IN mM_NN unless_IN otherwise_RB noted_VBD ._. Intracellular_NNP (_( or_CC
          recording_NN electrode_NN )_) solution_NN :_: KCl_NNP 120_CD ,_, MgCl_NNP 
          2_CD 2_CD ,_, HEPES_NNP 10_CD ,_, K_NNP 
          4_CD BAPTA_NNP 1_CD ,_, ATP_NNP 1_CD ._. 15_CD ,_, GTP_NNP 0_CD ._. 4_CD ,_, pH_NN 6_CD ._. 8_CD
          (_( with_IN KOH_NNP )_) ._. Extracellular_NNP solution_NN :_: NaCl_NNP 118_CD ,_, KCl_NNP 2_CD ._. 4_CD ,_,
          CaCl_NNP 
          2_CD 1_CD ._. 8_CD ,_, MgCl_NNP 
          2_CD 1_CD ._. 8_CD ,_, sodium_NN pyruvate_NN 5_CD ,_, glucose_NN 5_CD ,_,
          HEPES_NNP 10_CD ,_, TTX_NNP 0_CD ._. 0003_CD ,_, pH_NN 7_CD ._. 4_CD (_( with_IN NaOH_NNP )_) ._. Growth_NN medium_NN :_:
          NaCl_NNP 118_CD ,_, KCl_NNP 2_CD ._. 4_CD ,_, creatine_NN 5_CD ._. 7_CD ,_, glucose_NN 5_CD ,_, sodium_NN
          pyruvate_NN 5_CD ,_, 100_CD ×_NN MEM_NNP vitamins_NNS 10_CD ml_NN /_NN L_NNP ,_, penicillin_NN 100_CD
          U_NNP /_NN ml_NN ,_, streptomycin_NN 100_CD μg_NN /_NN ml_NN ,_, 50_CD ×_NN MEM_NNP essential_JJ amino_JJ
          acids_NNS 20_CD ml_NN /_NN L_NNP ,_, 100_CD ×_NN MEM_NNP non-essential_JJ amino_JJ acids_NNS 10_CD
          ml_NN /_NN L_NNP ,_, HEPES_NNP 20_CD ,_, pH_NN 7_CD ._. 4_CD (_( with_IN NaOH_NNP )_) ._.
          I_PRP 
          M_NNP was_VBD monitored_VBN by_IN 500_CD ms_NNS pulses_NNS from_IN
          a_DT holding_VBG potential_NN of_IN -_: 30_CD mV_NN to_TO -_: 50_CD mV_NN every_DT 8_CD s_VBZ ._. The_DT
          recordings_NNS were_VBD filtered_VBN at_IN 1_CD kHz_NN and_CC stored_VBD on_IN magnetic_JJ
          tape_NN ._. The_DT I_PRP 
          M_NNP relaxations_NNS were_VBD sampled_VBN on_IN line_NN at_IN
          2_CD ._. 4_CD kHz_NN ._. I_PRP 
          M_NNP was_VBD measured_VBN as_IN the_DT amplitude_NN of_IN the_DT
          current_JJ tail_NN following_VBG a_DT voltage_NN step_NN from_IN -_: 50_CD mV_NN to_TO -_: 30_CD
          mV_NN [_NN 21_CD ]_NN ._. To_TO quantify_VB the_DT inhibition_NN of_IN I_PRP 
          M_NNP ,_, the_DT current_NN before_IN drug_NN and_CC at_IN the_DT
          maximum_NN inhibition_NN during_IN each_DT response_NN were_VBD measured_VBN and_CC
          the_DT percentage_NN of_IN inhibition_NN of_IN I_PRP 
          M_NNP was_VBD calculated_VBN ._.
        
        
          Statistical_NNP Analysis_NNP
          The_DT percent_NN of_IN ionomycin_NN data_NNS from_IN the_DT Ca_MD +_NN +_NN elevation_NN
          experiments_NNS and_CC the_DT B_NN /_NN B_NNP 
          0_CD data_NNS from_IN the_DT binding_JJ experiments_NNS
          were_VBD both_DT subjected_VBN to_TO two-way_JJ ANOVA_NNP analysis_NN ,_, with_IN the_DT
          independent_JJ variables_NNS being_VBG fluorescent_NN conjugate_NN and_CC
          dose_NN ._. One-way_NNP ANOVA_NNP analysis_NN was_VBD used_VBN to_TO describe_VB the_DT
          intensity_NN to_TO area_NN measurements_NNS from_IN the_DT fluorescent_NN
          images_NNS ,_, except_IN tetramethylrhodamine_NN ._. These_DT data_NNS ,_, like_IN the_DT
          data_NNS obtained_VBN from_IN the_DT binding_JJ assay_NN and_CC Ca_MD +_NN +_NN analysis_NN ,_,
          were_VBD analyzed_VBN for_IN variance_NN followed_VBN by_IN the_DT
          Student-_NNP Newman-_NNP Keuls_NNP test_NN ._.
        
      
    
  
